Mirko Duvnjak

Mr. Mirko Duvnjak

Chemistry Department, University of Zagreb, Faculty of Science, Zagreb, Zagreb, Grad, Croatia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2025 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Open access
MDMirko Duvnjak
Mirko Duvnjak
NVNikolina Vidovic
Nikolina Vidovic
KUKrunoslav Užarević
Krunoslav Užarević
GHGordan Horvat
Gordan Horvat
Vladislav TomisicVladislav Tomisic
Vladislav Tomisic
NCNikola Cindro
Nikola Cindro
A novel mechanochemical approach is described for chloride-templated head-to-tail macrocyclization of a pentapeptide and a hexapeptide. This straightforward method allows the solvent-free preparation of cyclopeptides with yields comparable to solution-based approaches without the need for high dilution of the reaction mixture and with significantly reduced reaction times and organic waste amount.

Verified
Journal Article
Open access
PDF file
MDMirko Duvnjak
Mirko Duvnjak
GTGregor Talajić
Gregor Talajić
JBJurica Baranasic
Jurica Baranasic
NTNea Baus Topić
Nea Baus Topić
HPHana Čipčić Paljetak
Hana Čipčić Paljetak
NCNikola Cindro
Nikola Cindro
Penicyclone A is a polyketide compound with a unique and intriguing structure recently isolated from the fungus Penicillium sp. F23-2 during an OSMAC (one-strain-many-compounds) campaign. The compound demonstrated significant antimicrobial activity without exhibiting any cytotoxic effects, which prompted us to pursue total synthesis of the reported enantiomer. Upon completion of the synthesis, we observed that our synthetic compound lacked antimicrobial activity. Further analysis suggested that the natural product may have, in fact, been the opposite enantiomer to that reported. This observation led us to synthesize the antipodal enantiomer using our previously developed synthetic sequence and to evaluate the biological activity (via antibacterial and cytotoxicity assays) of both the final compound and the selected intermediates from both enantiomeric series.